Practical Diabetes is a journal for healthcare professionals covering all aspects of diabetes care including type 1 and type 2 diabetes, obesity, new insulins and type 2 drugs, guidelines and policy issues and diabetes complications.
In the 2016 Health Readership Survey of Senior Doctors and Consultants in diabetes, Practical Diabetes was the most highly read diabetes journal with 86% of Consultants reading the journal in the last 12 months.

Latest News

GLP-1 receptor agonists: effect on CVD risk

Glucagon-like peptide-1 receptor agonists significantly reduce major cardiovascular events and mortality in patients with type 2 diabetes – whether they have...Read more

Roche offers direct support for starting insulin

Roche has launched a texting support service for people with type 2 diabetes who use its Accu-Check monitoring device and are starting treatment with a...Read more

Real life data show Freestyle Libre improves glycaemic control

People with type 1 or type 2 diabetes who use the Freestyle Libre device to monitor their glucose levels improve their glycaemic control by several indicators,...Read more

Demands increase for better foot care

Diabetes UK has called on NHS England to keep the pledges made in the NHS Long Term Plan by ensuring ‘the investment promised for developing diabetes foot...Read more

Insulin discontinuation by older people with type 2 diabetes

Clinicians should do more to reduce treatment intensity in older people with type 2 diabetes as their health deteriorates, say US researchers. Their analysis...Read more

The sugary season of goodwill

Some of the comforting and seasonal milk-based drinks on offer from retail coffee chains contain enormous amounts of sugar and are very high in calories, the...Read more

Featured Articles

Coronavirus and diabetes: an update
On March 11 the WHO declared the COVID-19 outbreak a pandemic. Updated morbidity and mortality data can be accessed online with most fatalities reported in ‘at risk groups’. According to the CDC ‘at risk groups’ includes people with diabetes. This editorial discusses the impact of COVID-19 upon diabetes care.
Click here to view

Diabetes specialist nurse point-of-care review service: improving clinical outcomes for people with diabetes on emergency wards
It is well established that inpatients with diabetes are associated with poorer clinical outcomes. We therefore investigated the effects of introducing a point-of-care (POC) ward-based glucose and ketones assessment to trigger a diabetes inpatient specialist nurse (DISN) proactive review to the ward, on the length of stay (LOS), 30-day readmission rate and 30-day mortality rate.
Click here to view

Insulin hypersensitivity in type 1 diabetes: investigation and treatment with immunodepletion
Type 1 diabetes is an auto-immune disease commonly associated with other autoimmune conditions. Generation of IgG anti-insulin antibodies may cause deposition of antibody-insulin complexes with local cutaneous inflammatory reactions, or systemic symptoms of serum sickness. Where clinical features are severe and associated with insulin resistance, treatment with immunosuppressants, intravenous immunoglobulin, plasmapheresis or rituximab may be considered.
Click here to view

Web design and marketing agency Leamington Spa